This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Dab2: How to attenuate brain injury due to Alzheimer's disease?

March 25th, 2014

Transforming growth factor-beta (TGF-β) type II receptor (TβRII) levels are extremely low in the brain tissue of patients with Alzheimer's disease. This receptor inhibits TGF-β1/SMAD signaling and thereby aggravates amyolid-beta deposition and neuronal injury. Dab2, a specifc adapter protein, protects TβRII from degradation and ensures the effective conduction of TGF-β1/SMAD signaling.

Prof. Jun Liu and team from Norman Bethune First Hospital of Jilin University in China used an adenoviral vector to overexpress Dab2 in the APP/PS1 transgenic mouse model of Alzheimer's disease, and investigated the regulatory effect of Dab2 protein on transforming growth factor-β1/SMAD signaling and brain injury in Alzheimer's disease. They found that after Dab2 expression, hippocampal TβRII and p-SMAD2/3 levels were significantly increased, while amyloid-beta deposition, microglia activation, tumor necrosis factor-β and interleulin-6 levels and neuronal loss were signifcantly attenuated in APP/PS1 mouse brain tissue.

These findings, published in the Neural Regeneration Research (Vol. 9, No. 1, 2014), suggest that Dab2 can exhibit neuroprotective effects in Alzheimer's disease by regulating TGF-β1/SMAD signaling.

Provided by Neural Regeneration Research

Citation: Dab2: How to attenuate brain injury due to Alzheimer's disease? (2014, March 25) retrieved 25 July 2026 from https://sciencex.com/wire-news/157196669/dab2-how-to-attenuate-brain-injury-due-to-alzheimers-disease.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.